Atrial Fibrillation in Hypertrophic Cardiomyopathy

QR Code

Atrial Fibrillation in Hypertrophic Cardiomyopathy

The current information about features of atrial fibrillation in patients with hypertrophic cardiomyopathy is presented in this review. The data about prevalence, pathogenesis and its various complications in these patients are disclosed. The article contains updated clinical recommendations of auth...

Full description

Saved in:

Bibliographic Details
Main Authors:	G. A. Ignatenko, G. G. Taradin, N. T. Vatutin, A. A. Kaluga, Yu. D. Kostyamin
Format:	Article
Language:	Russian
Published:	SINAPS LLC 2021-05-01
Series:	Архивъ внутренней медицины
Subjects:	hypertrophic cardiomyopathy cardiac arrhythmias atrial fibrillation risk factors anticoagulant therapy antiarrhythmic therapy left ventricular outflow tract obstruction catheter ablation
Online Access:	https://www.medarhive.ru/jour/article/view/1233
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Septal alcohol ablation in patients with hypertrophic cardiomyopathy and left ventricular outflow tract obstruction
by: Mariia S. Nozdriakova, et al.
Published: (2025-01-01)

Effect of salt intake on clinical course and hemodynamics in patients with hypertrophic cardiomyopathy
by: N. G. Poteshkina, et al.
Published: (2022-01-01)

THE UNRESOLVED ISSUES AND MODERN VIEW ON ATRIAL FIBRILLATION PATIENTS MANAGEMENT
by: D. V. Losik, et al.
Published: (2017-08-01)

Infective Endocarditis in Patients with Hypertrophic Cardiomyopathy
by: E. Yu. Ponomareva, et al.
Published: (2021-09-01)

ATRIAL FIBRILLATION AND FLUTTER IN HYPERTROPHIC CARDIOMYOPATHY
by: N. S. Krylova, et al.
Published: (2015-05-01)

Pulsed field ablation for ventricular arrhythmias with pentaspline catheter
by: Anna Padisak, et al.
Published: (2025-07-01)

2020 Clinical practice guidelines for Hypertrophic cardiomyopathy
by: S. A. Gabrusenko, et al.
Published: (2021-06-01)

Antiarrhythmic drug therapy after atrial fibrillation ablation: data of the ESC-EHRA registry
by: L. E. Korobchenko, et al.
Published: (2020-06-01)

HYPERTROPHIC CARDIOMYOPATHY: GENETIC ALTERATIONS, PATHOGENESIS AND PATHOPHYSIOLOGY
by: N. T. Vatutin, et al.
Published: (2014-05-01)

Contrast Enhanced Echocardiography-Controlled Alcohol Septal Ablation for Hypertrophic Cardiomyopathy with Left Ventricular Outflow Tract Obstruction
by: I. E. Nikolaeva, et al.
Published: (2019-07-01)

Apical hypertrophic cardiomyopathy: contemporary view on the prevalence, clinical profile, diagnostic and treatmen (review of literature)
by: A. A. Streltsova, et al.
Published: (2021-10-01)

A Narrative Review of Current and Investigational Therapies in Hypertrophic Cardiomyopathy
by: Ian Ogurek, et al.
Published: (2025-05-01)

Specifics of Left Ventricular Hypertrophy and Characteristic of Phenotypic Variants in Patients with Hypertrophic Cardiomyopathy
by: G. I. Ignatenko, et al.
Published: (2023-08-01)

LEFT VENTRICULAR WALL THICKNESS AND AUTONOMIC REGULATION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
by: O. Allaberganov, et al.
Published: (2011-10-01)

Results of catheter ablation in patients with idiopathic premature ventricular contractions depending on the use of fluoroscopy
by: A. A. Vyrva, et al.
Published: (2020-08-01)

INFLUENCE OF THE POLYMORPHISM OF THE RENIN-ANGIOTENSIN SYSTEM GENES ON THE CARDIAC ARRHYTHMIAS IN CHILDREN WITH HYPERTROPHIC CARDIOMYOPATHY
by: N. A. Berezneva, et al.
Published: (2013-05-01)

Premature ventricular contractions in children: classification, approaches to observation and treatment
by: T. K. Kruchina, et al.
Published: (2021-06-01)

AMIODARONE THYROTOXICOSIS IN A PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY
by: P. Kh. Dzhanashiya, et al.
Published: (2009-06-01)

Clinical variants, outcomes and prognosis of hypertrophic non-obstructive cardiomyopathy: results of long-term follow-up
by: D. V. Bogdanov, et al.
Published: (2019-11-01)

CONTEMPORARY METHODS FOR MYOCARDIAL FUNCTION EVALUATION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY BEFORE AND AFTER SURGICAL TREATMENT
by: E. Yu. Van, et al.
Published: (2014-05-01)

RARE CASES OF HYPERTROPHIC CARDIOMYOPATHY: VARIANTS AND CLINICAL OBSERVATIONS
by: V. Yu. Zimina, et al.
Published: (2015-09-01)

Anticoagulant therapy in catheter ablation of atrial fibrillation and flutter
by: M. V. Serova, et al.
Published: (2021-09-01)

IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
by: P. Kh. Dzhanashiya, et al.
Published: (2010-02-01)

NEUROTROPIC MYOCARDIAL SCINTIGRAPHY IN THE EVALUATION OF SUDDEN CARDIAC DEATH PROGNOSIS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
by: A. A. Ansheles, et al.
Published: (2017-09-01)

Comparing the Impact of Different Antiarrhythmic Classes on Clinical Outcomes Following Atrial Fibrillation Catheter Ablation
by: Andrej Belančić, et al.
Published: (2025-07-01)

CHRONIC HEART FAILURE IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
by: N. S. Krylova, et al.
Published: (2011-04-01)

Prediction of antiarrhythmic therapy effectiveness in children
by: L. I. Svintsova, et al.
Published: (2019-08-01)

Development of predictive models for differential diagnosis of hypertrophic cardiomyopathy
by: V. V. Zaitsev, et al.
Published: (2024-12-01)

Echocardiographic predictors of outcomes in hypertrophic cardiomyopathy
by: Annamaria Del Franco, et al.
Published: (2023-10-01)

2014 ESC GUIDELINES ON DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY
by: Perry M. Elliott, et al.
Published: (2015-05-01)

MYOCARDIAL BIOPSY IN GENERAL CARE CLINIC: PATIENTS SELECTION, THE RESULTS, SIGNIFICANCE FOR TREATMENT STRATEGY
by: O. V. Blagova, et al.
Published: (2015-05-01)

Obstructive Hypertrophic Cardiomyopathy and Aortic Stenosis With High Surgical Risk
by: Omar M. Abdelfattah, MD, et al.
Published: (2025-07-01)

Effectiveness and safety of lidocaine use (review)
by: A. V. Matveev, et al.
Published: (2020-12-01)

PULSE REDUCTION IN MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY (TWO CLINICAL CASES)
by: N. S. Krylova, et al.
Published: (2017-12-01)

Sex Differences in Children and Adolescents With Hypertrophic Cardiomyopathy
by: Gabrielle Norrish, PhD, et al.
Published: (2025-08-01)

ASSOCIATIONS BETWEEN CLINICAL COURSE, LEFT VENTRICULAR HYPERTROPHY SEVERITY AND ACE GENE I/D POLYMORPHISM IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY AND HYPERTENSIVE HEART
by: M. D. Smirnova, et al.
Published: (2009-04-01)

Molecular genetic characteristics of patients with hypertrophic cardiomyopathy: a review
by: Yu. A. Yus'kiv, et al.
Published: (2024-12-01)

Clinical features of hypertrophic cardiomyopathy depending on the hereditary factor
by: V. G. Davydova, et al.
Published: (2023-08-01)

CURRENT PRINCIPLES AND TRENDS OF ATRIAL FIBRILLATION PHARMACOTHERAPY
by: Yu. A. Bunin
Published: (2016-01-01)

SUDDEN DEATH IN HYPERTROPHIC CARDIOMYOPATHY: SEARCH FOR NEW RISK FACTORS
by: N. S. Krylova, et al.
Published: (2017-02-01)